Riad Salem, MD
Vascular & Interventional Radiology · Chicago, ILNPI 1164447645
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,490,378 of the $2,282,122 with a category attached, or 65.3%. 30 manufacturers reported payments, led by Boston Scientific at 36.9% of the total. 2025 is the largest year on record at $555,008, 2.5 times the $222,429 reported in 2019. Among vascular & interventional radiology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 895 payments — averaging $2549.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$843K
- Bard Peripheral Vascular, Inc.$399K
- Trisalus Life Sciences, Inc.$265K
- Biocompatibles, Inc.$151K
- Sirtex Medical Inc$139K
- Eisai Inc.$99K
- plus $386K from 24 others
Across 7 payments — averaging $29,313 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$173K
- Cook Incorporated$20K
- Bard Peripheral Vascular, Inc.$11K
- F. Hoffmann-la Roche AG$2K
What the payments were for
- Consulting fees$1,490,37865%
- Speaking & faculty fees$387,70517%
- Grants$3,5000%
- Travel & lodging$253,67211%
- Food & beverage$22,6791%
- Education$4600%
- Other$123,7285%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 331 | $842,935 |
| Bard Peripheral Vascular, Inc. | 145 | $398,872 |
| Trisalus Life Sciences, Inc. | 16 | $265,484 |
| Biocompatibles, Inc. | 10 | $151,474 |
| Sirtex Medical Inc | 34 | $138,660 |
| Eisai Inc. | 58 | $98,891 |
| Siemens Medical Solutions USA, Inc. | 108 | $81,737 |
| AstraZeneca | 41 | $80,898 |
| Cook Incorporated | 18 | $69,705 |
| Merck | 28 | $24,233 |
| Astrazeneca UK Limited | 8 | $24,143 |
| Genentech USA, Inc. | 12 | $21,707 |
| Merit Medical Systems Inc | 5 | $17,422 |
| Angiodynamics, Inc. | 2 | $15,600 |
| W. L. Gore & Associates, Inc. | 11 | $10,440 |
| F. Hoffmann-la Roche AG | 6 | $10,270 |
| Incyte Corporation | 12 | $9,102 |
| Genentech, Inc. | 6 | $6,048 |
| Exelixis Inc. | 5 | $4,837 |
| Terumo Medical Corporation | 3 | $3,850 |
| Dova Pharmaceuticals | 2 | $2,353 |
| Fujifilm Healthcare Americas Corporation | 3 | $1,356 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $1,300 |
| Cook Medical LLC | 16 | $423 |
| Medtronic | 8 | $229 |
| Philips North America LLC | 1 | $66 |
| Penumbra, Inc. | 2 | $32 |
| Olympus America Inc. | 1 | $23 |
| Argon Medical Devices, Inc. | 1 | $19 |
| Biocompatibles UK Ltd | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TheraSphere Y90 Glass Microspheres 10 GBq$445,110
- TRINAV INFUSION SYSTEM$265,425
- GENERAL - THERAPIES$221,916
- THERASPHERE-BIO$151,474
- SIR-Spheres Microspheres$138,588
- LENVIMA$98,520
- TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)$56,873
- IMFINZI$32,813
- GENERAL PAIN MANAGEMENT$32,558
- THERASPHERE$30,893
- TECENTRIQ$27,935
- CLINICAL TRIAL PRODUCT$16,800
- Smart Port CT$15,600
- VIATORR Endoprosthesis$10,352
- Cook Medical Embolization$9,150
- Embosphere Microspheres$8,925
- Wrapsody Stent Graft$8,449
- MAGNETOM Free.Max$7,007
- Rosch-Uchida$6,995
- Cabometyx$4,606
How this compares
$2,282,122 in reported general payments places this provider in the 95th percentile of 197 vascular & interventional radiology providers in Illinois.
See all vascular & interventional radiology providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other vascular & interventional radiology in Chicago
- Kush DesaiChicago$1M
- Robert LewandowskiChicago$954K
- Christopher MolvarChicago$850K
- Sreekumar MadasseryChicago$459K
- Bulent ArslanChicago$300K
- Sameer AnsariChicago$161K
- Ahsun RiazChicago$127K
- Ramona GuptaChicago$72K
- Scott ResnickChicago$38K
- Erica AlexanderChicago$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.